Immunophenotyping and Functional Profiles of Peripheral Lymphocytes in Renal Transplant Recipients After T-Cell Depletion With Alemtuzumab (Anti-CD52 Monoclonal Antibody)-Potential Implications for Safe Immunosuppressive Minimization